Viewing Study NCT02805361


Ignite Creation Date: 2025-12-24 @ 12:50 PM
Ignite Modification Date: 2026-01-06 @ 9:06 PM
Study NCT ID: NCT02805361
Status: COMPLETED
Last Update Posted: 2019-07-15
First Post: 2016-06-09
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Real World Assessment of Clinical Outcome Changes -Including Month of Ramadan-for Dapagliflozin in Management of Type II Diabetes Mellitus
Sponsor: AstraZeneca
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Outcomes Module Eligibility Module Contacts Locations Module References Module